Company Neomed Research S.r.l. with Fiscal Code 16403794
recorded a turnover of 2024 of
1.499.224,
with a net profit of
864.078
and having an average number of employees of
9.
The company operates in the field of Cercetare-dezvoltare in alte stiinte naturale si inginerie having the NACE code 7219.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Neomed Research S.r.l.
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
323.535
298.499
411.142
844.494
561.198
487.997
622.641
940.199
498.016
1.499.224
Total Income - EUR
329.221
302.076
434.201
854.780
574.748
494.157
657.781
948.432
505.761
1.503.721
Total Expenses - EUR
172.875
183.076
278.737
258.686
377.446
317.491
287.501
395.032
405.692
541.078
Gross Profit/Loss - EUR
156.347
119.000
155.464
596.095
197.302
176.667
370.280
553.401
100.069
962.642
Net Profit/Loss - EUR
129.268
98.782
150.548
587.571
192.215
173.001
365.179
546.036
96.556
864.078
Employees
9
8
7
9
9
8
7
8
8
9
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 202.7%, from 498.016 euro in the year 2023, to 1.499.224 euro in 2024.
The Net Profit increased by 768.061 euro, from 96.556 euro in 2023, to 864.078 in the last year.
Check the financial reports for the company - Neomed Research S.r.l.
Financial Rating - NEOMED RESEARCH S.R.L.
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Neomed Research S.r.l.
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Neomed Research S.r.l.
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Neomed Research S.r.l.
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Neomed Research S.r.l. - CUI 16403794
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
216.921
246.352
268.026
265.369
247.429
223.935
252.052
236.142
221.073
237.802
Current Assets
140.910
190.568
235.666
607.340
432.096
334.088
304.632
785.141
210.083
1.079.544
Inventories
0
0
0
0
0
0
0
0
0
0
Receivables
73.307
129.609
31.200
449.491
217.796
128.176
116.750
526.419
61.939
721.153
Cash
67.602
60.959
204.466
157.849
214.300
205.911
187.882
258.722
148.144
358.391
Shareholders Funds
290.690
119.115
155.100
716.187
583.203
493.210
492.788
550.253
380.784
873.067
Social Capital
45
45
44
43
42
41
40
41
40
40
Debts
75.990
323.343
362.081
167.305
100.482
70.771
64.484
476.925
79.816
516.413
Income in Advance
0
0
0
0
0
0
3.959
2.957
1.937
921
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"7219 - 7219"
CAEN Financial Year
7219
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
1.079.544 euro in 2024 which includes Inventories of
0 euro, Receivables of
721.153 euro and cash availability of
358.391 euro.
The company's Equity was valued at
873.067 euro, while total Liabilities amounted to
516.413 euro.
Equity increased by 494.411 euro, from 380.784 euro in 2023, to 873.067 in 2024.
The Debt Ratio was 37.1% in the year 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Neomed Research S.r.l.